Eli Lilly (LLY) PT Lowered to $800 at DZ Bank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Novo Nordisk, Eli Lilly drop on Amgen competition concerns
May 3, 2024 7:15 AM EDT(Updated - May 3, 2024 7:48 AM EDT)
Shares of Novo Nordisk (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY) are down premarket Friday as competition in the GLP-1 market. Amgen (NASDAQ: AMGN) disclosed that it looked at AMG133's unblinded phase 2 interim trial and came away confident in 133's differentiated... More
